Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AAZTA: An Ideal Chelating Agent for the Development of 44 Sc PET Imaging Agents.
Nagy G, Szikra D, Trencsényi G, Fekete A, Garai I, Giani AM, Negri R, Masciocchi N, Maiocchi A, Uggeri F, Tóth I, Aime S, Giovenzana GB, Baranyai Z. Nagy G, et al. Angew Chem Int Ed Engl. 2017 Feb 13;56(8):2118-2122. doi: 10.1002/anie.201611207. Epub 2017 Jan 18. Angew Chem Int Ed Engl. 2017. PMID: 28097756
[Theranostics in prostate cancer].
Garai I, Nagy G, Bátyi F, Hascsi Z. Garai I, et al. Among authors: nagy g. Magy Onkol. 2020 Jun 10;64(2):133-137. Epub 2020 Jan 28. Magy Onkol. 2020. PMID: 32520006 Free article. Hungarian.
In Vivo Imaging of Hypoxia and Neoangiogenesis in Experimental Syngeneic Hepatocellular Carcinoma Tumor Model Using Positron Emission Tomography.
Kis A, Szabó JP, Dénes N, Vágner A, Nagy G, Garai I, Fekete A, Szikra D, Hajdu I, Matolay O, Méhes G, Mező G, Kertész I, Trencsényi G. Kis A, et al. Among authors: nagy g. Biomed Res Int. 2020 Aug 7;2020:4952372. doi: 10.1155/2020/4952372. eCollection 2020. Biomed Res Int. 2020. PMID: 32832549 Free PMC article.
Synthesis, Physicochemical, Labeling and In Vivo Characterization of 44Sc-Labeled DO3AM-NI as a Hypoxia-Sensitive PET Probe.
Szücs D, Csupász T, Szabó JP, Kis A, Gyuricza B, Arató V, Forgács V, Vágner A, Nagy G, Garai I, Szikra D, Tóth I, Trencsényi G, Tircsó G, Fekete A. Szücs D, et al. Among authors: nagy g. Pharmaceuticals (Basel). 2022 May 26;15(6):666. doi: 10.3390/ph15060666. Pharmaceuticals (Basel). 2022. PMID: 35745585 Free PMC article.
In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model.
Csikos C, Vágner A, Nagy G, Kálmán-Szabó I, Szabó JP, Ngo MT, Szoboszlai Z, Szikra D, Krasznai ZT, Trencsényi G, Garai I. Csikos C, et al. Among authors: nagy g. Diagnostics (Basel). 2023 Jan 8;13(2):236. doi: 10.3390/diagnostics13020236. Diagnostics (Basel). 2023. PMID: 36673046 Free PMC article.
In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model.
Kálmán-Szabó I, Képes Z, Fekete A, Vágner A, Nagy G, Szücs D, Gyuricza B, Arató V, Varga J, Kárpáti L, Garai I, Mándity I, Bruchertseifer F, Elek J, Szikra D, Trencsényi G. Kálmán-Szabó I, et al. Among authors: nagy g. J Pharm Biomed Anal. 2023 May 30;229:115374. doi: 10.1016/j.jpba.2023.115374. Epub 2023 Mar 28. J Pharm Biomed Anal. 2023. PMID: 37001274 Free article.
1,427 results